The Cantourage Group SE, a broad European supplier in the medical cannabis sector, started on December 19, 2024 and exported the first medical craft cannabis to Poland. This expansion is carried out within the framework of the partnership with the Polish pharmaceutical distributors PharmaVitae, with a long-term commitment. The development began with the Cannabissorte “Mac 1”, which exists in Germany and Great Britain. The partnership is planned until January 2025 for other products in the Cantourages portfolio to be available.

Cantourage Global Sales Director Bernhard Retzer was optimistic about the organization and responsibility of the partnership for supplying high-quality cannabis to Polish patients. Investment in the Polish market is based on the potential of the time, which is aufweist. PharmaVitae has a medical cannabis distribution network in current time and an average trust of more than 1,200 pharmacies, which has been the spokesperson and buyer of medical cannabis in Poland.